(0.21%) 5 142.25 points
(0.14%) 38 496 points
(0.31%) 17 901 points
(0.04%) $83.88
(0.78%) $1.938
(0.28%) $2 353.80
(0.62%) $27.71
(2.10%) $941.45
(-0.19%) $0.933
(-0.36%) $10.98
(-0.31%) $0.798
(1.31%) $93.08
2 days till quarter result
(amc 2024-05-01)
Expected move: +/- 10.12%
@ $50.10
发出时间: 15 Feb 2024 @ 04:44
回报率: 3.45%
上一信号: Feb 14 - 22:32
上一信号:
回报率: 0.62 %
Live Chart Being Loaded With Signals
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH)...
Stats | |
---|---|
今日成交量 | 586 484 |
平均成交量 | 490 706 |
市值 | 2.64B |
EPS | $0 ( 2024-04-25 ) |
下一个收益日期 | ( $-0.550 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -23.14 |
ATR14 | $0.0680 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-18 | Wood Larry L | Buy | 5 284 | Stock Option (Right to Buy) |
2024-04-18 | Wood Larry L | Buy | 3 054 | Common Stock |
2024-03-06 | Zadno Reza | Buy | 48 575 | Common Stock |
2024-03-06 | Zadno Reza | Buy | 42 311 | Stock Option (Right to Buy) |
2024-03-06 | Waters Kevin | Buy | 13 275 | Common Stock |
INSIDER POWER |
---|
2.97 |
Last 100 transactions |
Buy: 687 056 | Sell: 915 626 |
音量 相关性
PROCEPT BioRobotics 相关性 - 货币/商品
PROCEPT BioRobotics 财务报表
Annual | 2023 |
营收: | $136.19M |
毛利润: | $71.05M (52.17 %) |
EPS: | $-2.24 |
FY | 2023 |
营收: | $136.19M |
毛利润: | $71.05M (52.17 %) |
EPS: | $-2.24 |
FY | 2022 |
营收: | $75.01M |
毛利润: | $37.09M (49.44 %) |
EPS: | $-2.11 |
FY | 2021 |
营收: | $34.47M |
毛利润: | $15.87M (46.02 %) |
EPS: | $-1.782 |
Financial Reports:
No articles found.
PROCEPT BioRobotics
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。